细胞因子在药物性肝损伤中的研究现状及应用价值

张雨; 邵玥明; 秦婷婷; 殷鑫; 温晓玉

doi:10.3969/j.issn.1001-5256.2020.08.045

细胞因子在药物性肝损伤中的研究现状及应用价值

DOI: 10.3969/j.issn.1001-5256.2020.08.045

吉林大学第一医院肝胆胰内科

基金项目:

吉林省科技发展计划项目(20190201065JC)；

详细信息

中图分类号: R575
计量
- 文章访问数: 794
- HTML全文浏览量: 28
- PDF下载量: 186
- 被引次数: 0
出版历程
- 出版日期: 2020-08-20

Current research status and application value of cytokines in drug-induced liver injury

Department of Hepatology, The First Hospital of Jilin University

Research funding:

摘要

摘要:
药物性肝损伤(DILI)是指使用一种或多种药物后,由药物或其他代谢产物引起的肝脏损害。因药物种类繁多、不同个体之间差异较大等原因,DILI临床诊断存在诸多困难,寻找新的生物标志物成为学者们的研究热点。细胞因子在DILI尤其是特异质型DILI中具有关键作用。概述了不同细胞因子在DILI中的作用及其可预测DILI严重程度、评估预后等应用价值,认为细胞因子作为DILI生物标志物具有广阔的应用前景。
- 化学性与药物性肝损伤 /
- 细胞因子类 /
- 生物学标记,药理学
Abstract:
Drug-induced liver injury(DILI) refers to liver injury caused by one or more drugs or their metabolites after use.Due to the various types of drugs and large differences between individuals,there are many difficulties in the clinical diagnosis of DILI,and the search for new biomarkers has become a research hotspot.Related studies have shown that cytokines play a key role in DILI,especially idiosyncratic DILI.This article outlines the role of different cytokines in DILI and their value in predicting the severity and evaluating prognosis of DILI.It is pointed out that cytokines have a broad application prospect as biomarkers for DILI.
- chemical and drug induced liver injury /
- cytokines /
- biomarkers,pharmacological

HTML全文

参考文献(33)

[1] SGRO C,CLINARD F,OUAZIR K,et al. Incidence of druginduced hepatic injuries:A French population-based study[J]. Hepatology,2002,36(2):451-455.

[2] HOOFNAGLE JH,NAVARRO VJ. Drug-induced liver injury:Icelandic lessons[J]. Gastroenterology, 2013, 144(7):1335-1336.

[3] SHEN T,LIU Y,SHANG J,et al. Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology,2019,156(8):2230-2241.

[4] CHALASANI N,BONKOVSKY HL,FONTANA R,et al. Features and outcomes of 899 patients with drug-induced liver injury:The DILIN prospective study[J]. Gastroenterology,2015,148(7):1340-1352.

[5] ALI SE,WADDINGTON JC,PARK BK,et al. Definition of the chemical and immunological signals involved in drug-induced liver injury[J]. Chem Res Toxicol,2020,33(1):61-76.

[6] YANG X,TU RF,YANG JH. Research advances in drug-induced liver injury[J]. J Clin Hepatol,2020,36(3):509-513.(in Chinese)杨雪，涂荣芳，杨晋辉．药物性肝损伤的研究进展[J]．临床肝胆病杂志，2020,36(3):509-513.

[7] GOTO S,DEGUCHI J,NISHIO N,et al. Hepatotoxicants induce cytokine imbalance in response to innate immune system[J]. J Toxicol Sci,2015,40(3):389-404.

[8] GANDHI A,GUO T,GHOSE R. Role of c-Jun N-terminal kinase(JNK)in regulating tumor necrosis factor-alpha(TNF-alpha)mediated increase of acetaminophen(APAP)and chlorpromazine(CPZ)toxicity in murine hepatocytes[J]. J Toxicol Sci,2010,35(2):163-173.

[9] ZHAO SM. The effect and mechanism of tumor necrosis factor-αin different types of liver injury[D]. Shanghai:The Second Military Medical University,2019.(in Chinese)赵善民．肿瘤坏死因子-α在不同类型肝损伤中的作用及机制研究[D]．上海:中国人民解放军海军军医大学，2019.

[10] ZHANG L,ZHAN J,WU BH,et al. The role of TNF-αin acetaminophen-induced liver injury in rats[J]. Chin J Gastroenterol Hepatol,2014,23(10):1181-1183.(in Chinese)张蕾，詹俊，伍百贺，等．TNF-α在对乙酰氨基酚所致大鼠药物性肝损伤中的作用[J]．胃肠病学和肝病学杂志，2014,23(10):1181-1183.

[11] ZHU SN,ZHANG J,TAN QY,et al. Improvement effects of water extract of glycyrrhiza uralensis on acute hepatic injury caused by triptolide and its effects on the levels of IL-10 and TNF-αin rats[J]. China Pharm,2019,30(2):216-220.(in Chinese)朱胜楠，张靖，谭亲友，等．甘草水提物对雷公藤甲素致大鼠急性肝损伤的改善作用及对其体内IL-10、TNF-α水平的影响[J]．中国药房，2019,30(2):216-220.

[12] MA BX,CHEN WL,ZHENG T,et al. Expression levels of serum TNF-αin patients of Han and Uygur nationalities with liver injury caused by anti-tuberculosis drugs in Xinjiang[J]. Chin J Hosp Pharm,2017,37(24):2456-2459.(in Chinese)麻斌喜，陈伟岚，郑甜，等．汉族、维吾尔族抗结核药物性肝损害患者血清TNF-α表达水平的研究[J]．中国医院药学杂志，2017,37(24):2456-2459.

[13] LEE HC,LIAO CC,DAY YJ,et al. IL-17 deficiency attenuates acetaminophen-induced hepatotoxicity in mice[J]. Toxicol Lett,2018,292:20-30.

[14] YANG PJ,HUANG Y,LIU HB. Research advances in the association between interleukin-17 and liver diseases[J]. J Clin Hepatol,2017,33(9):1810-1814.(in Chinese)杨浦娟，黄祎，刘华宝．IL-17与肝脏疾病的相关性[J]．临床肝胆病杂志，2017,33(9):1810-1814.

[15] YANO A,HIGUCHI S,TSUNEYAMA K,et al. Involvement of immune-related factors in diclofenac-induced acute liver injury in mice[J]. Toxicology,2012,293(1-3):107-114.

[16] TAKAI S,HIGUCHI S,YANO A,et al. Involvement of immuneand inflammatory-related factors in flucloxacillin-induced liver injury in mice[J]. J Appl Toxicol,2015,35(2):142-151.

[17] WANG L,YANG RN. Study on role and clinical significance of IL-9,IL-10 in immune liver damage[J]. Lab Med Clin,2017,14(20):3011-3014.(in Chinese)王兰，杨瑞宁．IL-9、IL-10在免疫性肝损伤中的作用及临床意义[J]．检验医学与临床，2017,14(20):3011-3014.

[18] FENG D,WANG Y,XU Y,et al. Interleukin 10 deficiency exacerbates halothane induced liver injury by increasing interleukin 8 expression and neutrophil infiltration[J]. Biochem Pharmacol,2009,77(2):277-284.

[19] JIA L,WU C. The biology and functions of Th22 cells[J].Adv Exp Med Biol,2014,841:209-230.

[20] HUANG MS. The research progress of the relationship between interleukin-22 with liver disease[D]. Nanchang:Nanchang University,2017.(in Chinese)黄梦姗．白细胞介素22与肝脏疾病关系的研究进展[D]．南昌:南昌大学，2017.

[21] SCHEIERMANN P,BACHMANN M,GOREN I,et al. Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury[J]. Am J Pathol,2013,182(4):1107-1113.

[22] LAI R,XIANG X,MO R,et al. Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury[J]. J Hepatol,2015,63(1):148-155.

[23] NJOKU DB,LI Z,MELLERSON JL,et al. IP-10 protects while MIP-2 promotes experimental anesthetic hapten-induced hepatitis[J]. J Autoimmun,2009,32(1):52-59.

[24] REN S,DU XF,HUANG YL,et al. Serum interferon-gamma-induced protein-10 level and gene polymorphism in patients with drug-induced liver injury accompanied by autoimmune phenomena[J]. J Clin Hepatol,2020,36(3):602-607.(in Chinese)任姗，杜晓菲，黄云丽，等．药物性肝损伤伴自身免疫现象患者血清γ干扰素诱导蛋白10水平及其单核苷酸多态性[J]．临床肝胆病杂志，2020,36(3):602-607.

[25] XIE Z,CHEN E,OUYANG X,et al. Metabolomics and cytokine analysis for identification of severe drug-induced liver injury[J]. J Proteome Res,2019,18(6):2514-2524.

[26] MASUBUCHI Y,BOURDI M,REILLY TP,et al. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease[J]. Biochem Biophys Res Commun,2003,304(1):207-212.

[27] BACHMANN M,PFEILSCHIFTER J,MHL H. A prominent role of interleukin-18 in acetaminophen-induced liver injury advocates its blockage for therapy of hepatic necroinflammation[J]. Front Immunol,2018,9:161.

[28] ZHANG X,SONG YF,ZHANG XS,et al. Fibroblast growth factor1 protects acetaminophe-induced liver injury in mice by inhibiting endoplasmic reticulum stress and autophagy[J]. Zhejiang Med J,2019,41(17):1840-1844,1916.(in Chinese)张谢，宋毓飞，张学松，等．FGF1通过抑制内质网应激和自噬途径保护对乙酰氨基酚诱导的小鼠肝损伤[J]．浙江医学，2019,41(17):1840-1844,1916.

[29] YAN YJ,WEN HR,DAN M,et al. Effects of three polygonum multiflorum monomers on liver injury in rats[J]. Modern Chin Med,2019,21(8):1054-1061.(in Chinese)颜玉静，文海若，淡墨，等．三种何首乌单体成分对大鼠肝损伤作用的研究[J]．中国现代中药，2019,21(8):1054-1061.

[30] LI C,MING Y,HONG W,et al. Comparison of hepatic transcriptome profiling between acute liver injury and acute liver failure induced by acetaminophen in mice[J]. Toxicol Lett,2018,283:69-76.

[31] MENG HJ,YANG XY,QIN HJ,et al. The predictive effect of inflammatory cytokines against the hepatic injury of tuberculous drugs[J]. J Pract Med,2019,35(2):238-241.(in Chinese)孟慧杰，杨雪迎，覃红娟，等．炎症细胞因子对抗结核性药物肝损伤的预测作用[J]．实用医学杂志，2019,35(2):238-241.

[32] STEUERWALD NM,FOUREAU DM,NORTON HJ,et al. Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance[J]. PLo S One,2013,8(12):e81974.

[33] BONKOVSKY HL,BARNHART HX,FOUREAU DM,et al. Cytokine profiles in acute liver injury-Results from the US DrugInduced Liver Injury Network(DILIN)and the acute liver failure study group[J]. PLo S One,2018,13(10):e0206389.

施引文献

资源附件(0)

访问统计